Factors associated with serum CA125 level in women without ovarian cancer in the United States: a population-based study

被引：0
|
作者：
Xiao Hu
Jingzhou Zhang
Yu Cao
机构：
[1] Tufts Medical Center,Division of Hematology
[2] Boston University School of Medicine,Oncology, Department of Medicine
来源：
BMC Cancer | / 22卷
关键词：
CA125; Epidemiology; Ovarian cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Factors associated with serum CA125 level in women without ovarian cancer in the United States: a population-based study
    Hu, Xiao
    Zhang, Jingzhou
    Cao, Yu
    BMC CANCER, 2022, 22 (01)
  • [2] Serum CA125 level before the development of ovarian cancer
    Kobayashi, H.
    Ooi, H.
    Yamada, Y.
    Sakata, M.
    Kawaguchi, R.
    Kanayama, S.
    Sumimoto, K.
    Terao, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2007, 99 (02) : 95 - 99
  • [3] Preoperative LMR and Serum CA125 Level as Risk Factors for Advanced Stage of Ovarian Cancer
    Tang, Ying
    Hu, Hui-Quan
    Tang, Ya-Lan
    Tang, Fang-Xiang
    Zheng, Xue-Mei
    Deng, Li-Hong
    Yang, Ming-Tao
    Yin, Su
    Li, Jun
    Xu, Fan
    JOURNAL OF CANCER, 2021, 12 (19): : 5923 - 5928
  • [4] CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients - From The Danish "MALOVA" Ovarian Cancer Study
    Hogdall, Estrid V. S.
    Christensen, Lise
    Kjaer, Susanne K.
    Blaakaer, Jan
    Kjaerbye-Thygesen, Anette
    Gayther, Simon
    Jacobs, Ian J.
    Hogdall, Claus K.
    GYNECOLOGIC ONCOLOGY, 2007, 104 (03) : 508 - 515
  • [5] CA125 as a Marker of Heart Failure in the Older Women: A Population-Based Analysis
    Bulska-Bedkowska, Weronika
    Chelmecka, Elzbieta
    Owczarek, Aleksander J.
    Mizia-Stec, Katarzyna
    Witek, Andrzej
    Szybalska, Aleksandra
    Grodzicki, Tomasz
    Olszanecka-Glinianowicz, Magdalena
    Chudek, Jerzy
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (05)
  • [6] CA125 nadir concentration is an independent predictor of tumor recurrence in patients with ovarian cancer: A population-based study
    van Altena, Anne M.
    Kolwijck, Eva
    Spanjer, Marielle J. B.
    Hendriks, Jan C. M.
    Massuger, Leon F. A. G.
    de Hullu, Joanne A.
    GYNECOLOGIC ONCOLOGY, 2010, 119 (02) : 265 - 269
  • [7] Prevalence of ovarian cancer among women with a CA125 level of 35 U/ml or less
    Kobayashi, Hiroshi
    Yamada, Yoshihiko
    Sado, Toshiyuki
    Sakata, Mariko
    Yoshida, Shozo
    Kawaguchi, Ryuji
    Kanayama, Seiji
    Shigetomi, Hiroshi
    Haruta, Shoji
    Tsuji, Yoriko
    Ueda, Sachiyo
    Kitanaka, Takashi
    Oi, Hidekazu
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2008, 65 (02) : 133 - 138
  • [8] CA125 Level Association With Chemotherapy Toxicity and Functional Status in Older Women With Ovarian Cancer
    Won, Elizabeth
    Hurria, Arti
    Feng, Tao
    Mohile, Supriya
    Owusu, Cynthia
    Klepin, Heidi D.
    Gross, Cary P.
    Lichtman, Stuart M.
    Gajra, Ajeet
    Tew, William P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (06) : 1022 - 1028
  • [9] Chronic Medical Conditions and CA125 Levels among Women without Ovarian Cancer
    Akinwunmi, Babatunde O.
    Babic, Ana
    Vitonis, Allison F.
    Cramer, Daniel W.
    Titus, Linda
    Tworoger, Shelley S.
    Terry, Kathryn L.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (12) : 1483 - 1490
  • [10] CA125 based diagnosis and therapy in recurrent ovarian cancer
    Meier, W
    Baumgartner, L
    Stieber, P
    Hasholzner, U
    FatehMoghadam, A
    ANTICANCER RESEARCH, 1997, 17 (4B) : 3019 - 3020
12345